{"id":"https://openalex.org/W2605872007","doi":"https://doi.org/10.1007/s13300-017-0261-8","title":"Assessment of Saxagliptin Efficacy: Meta-Analysis of 14 Phase 2 and 3 Clinical Trials","display_name":"Assessment of Saxagliptin Efficacy: Meta-Analysis of 14 Phase 2 and 3 Clinical Trials","alternate_titles":[],"publication_year":2017,"publication_date":"2017-04-21","ids":{"openalex":"https://openalex.org/W2605872007","doi":"https://doi.org/10.1007/s13300-017-0261-8","mag":"2605872007","pmid":"https://pubmed.ncbi.nlm.nih.gov/28432619","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/5446386"},"language":"en","primary_location":{"id":"doi:10.1007/s13300-017-0261-8","doi":"https://doi.org/10.1007/s13300-017-0261-8","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s13300-017-0261-8","pdf_url":"https://link.springer.com/content/pdf/10.1007%2Fs13300-017-0261-8.pdf","source":{"id":"https://openalex.org/S16535137","display_name":"Diabetes Therapy","issn_l":"1869-6961","issn":["1869-6961","1869-6953"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Therapy","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2605872007"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://link.springer.com/content/pdf/10.1007%2Fs13300-017-0261-8.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5030399648","display_name":"Mikaela Sj\u00f6strand","orcid":"https://orcid.org/0000-0001-6253-9886","observed_orcids":["https://orcid.org/0000-0001-6253-9886"]},"institutions":[{"id":"https://openalex.org/I4210143795","display_name":"AstraZeneca (Sweden)","ror":"https://ror.org/04wwrrg31","country_code":"SE","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210143795"]}],"countries":["SE"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Mikaela Sj\u00f6strand","raw_affiliation_strings":["AstraZeneca, Gothenburg, Sweden. mikaela.sjostrand@astrazeneca.com","AstraZeneca, Gothenburg, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca, Gothenburg, Sweden. mikaela.sjostrand@astrazeneca.com","institution_ids":["https://openalex.org/I4210143795"]},{"raw_affiliation_string":"AstraZeneca, Gothenburg, Sweden","institution_ids":["https://openalex.org/I4210143795"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109062713","display_name":"Cheryl Wei","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Cheryl Wei","raw_affiliation_strings":["AstraZeneca, Gaithersburg, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca, Gaithersburg, MD, USA","institution_ids":["https://openalex.org/I4210150756"]}]},{"author_position":"middle","author":{"id":null,"display_name":"William Cook","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"William Cook","raw_affiliation_strings":["MedImmune, Gaithersburg, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MedImmune, Gaithersburg, MD, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062793550","display_name":"Kristina M. Johnsson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210143795","display_name":"AstraZeneca (Sweden)","ror":"https://ror.org/04wwrrg31","country_code":"SE","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210143795"]}],"countries":["SE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Kristina Johnsson","raw_affiliation_strings":["AstraZeneca, Gothenburg, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca, Gothenburg, Sweden","institution_ids":["https://openalex.org/I4210143795"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024617569","display_name":"Pia S. Pollack","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Pia S. Pollack","raw_affiliation_strings":["AstraZeneca, Gaithersburg, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca, Gaithersburg, MD, USA","institution_ids":["https://openalex.org/I4210150756"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111493284","display_name":"Christina Stahre","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210143795","display_name":"AstraZeneca (Sweden)","ror":"https://ror.org/04wwrrg31","country_code":"SE","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210143795"]}],"countries":["SE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Christina Stahre","raw_affiliation_strings":["AstraZeneca, Gothenburg, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca, Gothenburg, Sweden","institution_ids":["https://openalex.org/I4210143795"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5072950568","display_name":"Boaz Hirshberg","orcid":"https://orcid.org/0000-0003-2829-3602","observed_orcids":["https://orcid.org/0000-0003-2829-3602"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Boaz Hirshberg","raw_affiliation_strings":["MedImmune, Gaithersburg, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MedImmune, Gaithersburg, MD, USA","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5030399648"],"corresponding_institution_ids":["https://openalex.org/I4210143795"],"apc_list":{"value":7400,"currency":"USD","value_usd":7400},"apc_paid":{"value":7400,"currency":"USD","value_usd":7400},"fwci":0.2763,"has_fulltext":true,"cited_by_count":10,"citation_normalized_percentile":{"value":0.25589764,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":96},"biblio":{"volume":"8","issue":"3","first_page":"587","last_page":"599"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12539","display_name":"Pharmacology and Obesity Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/saxagliptin","display_name":"saxagliptin","score":0.9980000257492065},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9570000171661377},{"id":"https://openalex.org/keywords/hba1c","display_name":"HbA1c","score":0.8140000104904175},{"id":"https://openalex.org/keywords/hba1c-reduction","display_name":"HbA1c reduction","score":0.8100000023841858},{"id":"https://openalex.org/keywords/dpp-4-inhibitors","display_name":"DPP-4 inhibitors","score":0.847000002861023},{"id":"https://openalex.org/keywords/adjunctive-therapy","display_name":"adjunctive therapy","score":0.8109999895095825},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.765999972820282},{"id":"https://openalex.org/keywords/monotherapy","display_name":"monotherapy","score":0.8479999899864197},{"id":"https://openalex.org/keywords/sulfonylureas","display_name":"sulfonylureas","score":0.8500000238418579},{"id":"https://openalex.org/keywords/renal-dysfunction","display_name":"renal dysfunction","score":0.9810000061988831},{"id":"https://openalex.org/keywords/glycemic-control","display_name":"glycemic control","score":0.6589999794960022},{"id":"https://openalex.org/keywords/age-and-sex-differences","display_name":"age and sex differences","score":0.5569999814033508},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.4309999942779541},{"id":"https://openalex.org/keywords/hypoglycemia","display_name":"hypoglycemia","score":0.7730000019073486},{"id":"https://openalex.org/keywords/hyperglycemia","display_name":"hyperglycemia","score":0.5590000152587891},{"id":"https://openalex.org/keywords/renal-adverse-events","display_name":"renal adverse effects","score":0.3720000088214874}],"concepts":[{"id":"https://openalex.org/C2780282729","wikidata":"https://www.wikidata.org/wiki/Q3121121","display_name":"Saxagliptin","level":5,"score":0.9889633655548096},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8819387555122375},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.7397047281265259},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6688240766525269},{"id":"https://openalex.org/C2778854520","wikidata":"https://www.wikidata.org/wiki/Q418776","display_name":"Sulfonylurea","level":3,"score":0.5761680006980896},{"id":"https://openalex.org/C2776999253","wikidata":"https://www.wikidata.org/wiki/Q1304270","display_name":"Combination therapy","level":2,"score":0.5244044065475464},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.4689587652683258},{"id":"https://openalex.org/C2777538456","wikidata":"https://www.wikidata.org/wiki/Q311213","display_name":"Glycated hemoglobin","level":4,"score":0.45560306310653687},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.4516070783138275},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3467082679271698},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.16185665130615234},{"id":"https://openalex.org/C2779284873","wikidata":"https://www.wikidata.org/wiki/Q419832","display_name":"Sitagliptin","level":4,"score":0.12947559356689453},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.07330682873725891},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.1007/s13300-017-0261-8","doi":"https://doi.org/10.1007/s13300-017-0261-8","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s13300-017-0261-8","pdf_url":"https://link.springer.com/content/pdf/10.1007%2Fs13300-017-0261-8.pdf","source":{"id":"https://openalex.org/S16535137","display_name":"Diabetes Therapy","issn_l":"1869-6961","issn":["1869-6961","1869-6953"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Therapy","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:4316625","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/5446386","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:5446386","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC5446386/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Ther","raw_type":"Text"},{"id":"pmid:28432619","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/28432619","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes therapy : research, treatment and education of diabetes and related disorders","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1007/s13300-017-0261-8","doi":"https://doi.org/10.1007/s13300-017-0261-8","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s13300-017-0261-8","pdf_url":"https://link.springer.com/content/pdf/10.1007%2Fs13300-017-0261-8.pdf","source":{"id":"https://openalex.org/S16535137","display_name":"Diabetes Therapy","issn_l":"1869-6961","issn":["1869-6961","1869-6953"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Therapy","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/systematic-review","display_name":"Systematic Review"},{"id":"https://openalex.org/study-designs/meta-analysis","display_name":"Meta-Analysis"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320307770","display_name":"AstraZeneca","ror":"https://ror.org/04r9x1a08"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2605872007.pdf","grobid_xml":"https://content.openalex.org/works/W2605872007.grobid-xml"},"referenced_works_count":55,"referenced_works":["https://openalex.org/W100598291","https://openalex.org/W1486033897","https://openalex.org/W1548863206","https://openalex.org/W1605983684","https://openalex.org/W1963542379","https://openalex.org/W1970125713","https://openalex.org/W1971471384","https://openalex.org/W1982202068","https://openalex.org/W1993472763","https://openalex.org/W2006247067","https://openalex.org/W2007221722","https://openalex.org/W2009999012","https://openalex.org/W2025791731","https://openalex.org/W2031195667","https://openalex.org/W2032322539","https://openalex.org/W2033331104","https://openalex.org/W2037434990","https://openalex.org/W2045063167","https://openalex.org/W2045321591","https://openalex.org/W2048728983","https://openalex.org/W2054564814","https://openalex.org/W2059623316","https://openalex.org/W2064130493","https://openalex.org/W2073229674","https://openalex.org/W2079644358","https://openalex.org/W2103058881","https://openalex.org/W2104239190","https://openalex.org/W2104763836","https://openalex.org/W2109728760","https://openalex.org/W2116492775","https://openalex.org/W2126065052","https://openalex.org/W2127854619","https://openalex.org/W2128050336","https://openalex.org/W2139923324","https://openalex.org/W2142830692","https://openalex.org/W2144325462","https://openalex.org/W2146264128","https://openalex.org/W2150483909","https://openalex.org/W2153552938","https://openalex.org/W2157891776","https://openalex.org/W2161852973","https://openalex.org/W2164282118","https://openalex.org/W2171294019","https://openalex.org/W2193379135","https://openalex.org/W2196906371","https://openalex.org/W2282578582","https://openalex.org/W2302447233","https://openalex.org/W2337454357","https://openalex.org/W2406839919","https://openalex.org/W2425644022","https://openalex.org/W2519510391","https://openalex.org/W2772390855","https://openalex.org/W2789732774","https://openalex.org/W4231460044","https://openalex.org/W4239088940"],"related_works":["https://openalex.org/W2103058881","https://openalex.org/W2803265237","https://openalex.org/W2045321591","https://openalex.org/W2217788221","https://openalex.org/W2126065052","https://openalex.org/W2512797700","https://openalex.org/W2113412141","https://openalex.org/W1970125713","https://openalex.org/W2055512303"],"abstract_inverted_index":{"INTRODUCTION:":[0],"This":[1],"meta-analysis":[2,260],"of":[3,253,258,264,270],"data":[4],"from":[5,94,109,239],"14":[6],"phase":[7],"2":[8,28],"and":[9,15,57,101,129,158,182,188,194,210,241,248],"3,":[10],"double-blind,":[11],"randomized,":[12],"controlled":[13],"12-":[14],"24-week":[16],"studies":[17,119],"(N":[18],"=":[19,46,53,59,69,85],"4632)":[20],"summarizes":[21],"saxagliptin":[22,37,79,100,114,217,265],"efficacy":[23,266],"in":[24,159,169,232,243,267],"patients":[25,160,176,203,271],"with":[26,75,113,161,216,219,229,272],"type":[27],"diabetes":[29],"(T2D)":[30],"across":[31,104,199,274],"treatment":[32,105,122,200,275],"regimens.":[33,106,201,276],"METHODS:":[34],"Patients":[35,74],"received":[36,78],"5":[38],"mg/d":[39,81],"or":[40,64,82,221],"control":[41,72,102,116,156,172,226],"as":[42,132],"either":[43],"monotherapy":[44,133],"(n":[45,52,68,84],"1196":[47],"vs":[48,55,61,71,141,146,155,208,214],"placebo),":[49],"add-on":[50,137],"therapy":[51,67,151],"2139":[54],"placebo":[56,83,220],"n":[58],"514":[60],"uptitrated":[62,147],"sulfonylurea),":[63,148],"initial":[65,149],"combination":[66,150],"619":[70],"monotherapy).":[73],"renal":[76,162],"impairment":[77,163],"2.5":[80],"164).":[86],"RESULTS:":[87],"Mean":[88],"baseline":[89,110,240],"glycated":[90],"hemoglobin":[91],"(A1C)":[92],"ranged":[93],"8.07%":[95],"to":[96],"9.43%":[97],"for":[98,117,175,189],"the":[99,236,249,262],"groups":[103],"A1C":[107,170,205,211],"reduction":[108,231],"was":[111,227],"greater":[112],"versus":[115,171,225],"all":[118],"combined":[120],"(mean":[121],"difference":[123],"[95%":[124],"CI]:":[125],"-0.55%":[126],"[-0.63%,":[127],"-0.47%])":[128,198],"when":[130],"used":[131],"(-0.52%":[134],"[-0.63,":[135],"-0.40%]),":[136],"(-0.55%":[138,179,196],"[-0.69%,":[139,186,192],"-0.40%]":[140],"placebo;":[142],"-0.72%":[143],"[-0.88%,":[144],"-0.56%]":[145],"(-0.54%":[152,185,191],"[-0.73%,":[153],"-0.35%]":[154],"monotherapy),":[157],"(-0.42%":[164],"[-0.75%,":[165],"-0.09%]).":[166],"Similar":[167],"reductions":[168],"were":[173],"noted":[174],"<65":[177],"years":[178,184],"[-0.67%,":[180],"-0.43%])":[181],"\u226565":[183],"-0.38%])":[187],"men":[190],"-0.40%])":[193],"women":[195],"[-0.64%,":[197],"More":[202],"achieved":[204],"<7%":[206],"(39%":[207],"23%)":[209],"\u22646.5%":[212],"(24%":[213],"14%)":[215],"than":[218],"active-control":[222],"treatment.":[223],"Saxagliptin":[224],"associated":[228],"a":[230],"glucagon":[233],"area":[234],"under":[235],"curve":[237],"(AUC)":[238],"increases":[242],"insulin":[244],"AUC,":[245,247],"C-peptide":[246],"homeostasis":[250],"model":[251],"assessment":[252],"\u03b2-cell":[254],"function.":[255],"CONCLUSION:":[256],"Results":[257],"this":[259],"demonstrate":[261],"consistency":[263],"different":[268],"subgroups":[269],"T2D":[273],"FUNDING:":[277],"AstraZeneca.":[278]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2605872007","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":3}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2017-04-28T00:00:00"}
